Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Thoracic Surgery

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 120 articles:
HTML format



Single Articles


    February 2025
  1. GAO XF, Kan J, Wu HY, Chen J, et al
    Intravascular Imaging-guided versus Angiography-guided Percutaneous Coronary Intervention in Patients with Diabetes Mellitus: Rationale and design of an International, Multicenter, Randomized IVI-DIABETES Trial.
    Am Heart J. 2025 Feb 4:S0002-8703(25)00017-1. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available


  2. WANG G, Zhang R, Chen SL, Wang J, et al
    Targeted Therapy with a Localized abluminal Groove Low-Dose Sirolimus-Eluting Bioabsorbable Polymer Coronary Stent in Chronic Total Occlusions: The TARGET CTO Non-Inferiority Randomized Trial.
    Am Heart J. 2025 Feb 3:S0002-8703(25)00018-3. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available


  3. NAKASE M, Tomii D, Maznyczka A, Heg D, et al
    Five-year outcomes with self-expanding versus balloon-expandable TAVI in patients with left ventricular systolic dysfunction.
    Am Heart J. 2025;280:18-29.
    PubMed     Abstract available


    January 2025
  4. EFTEKHARI A, Christiansen EH, Lassen JF, Raungaard B, et al
    Randomized comparison of the combined Sirolimus eluting and endothelial progenitor cell Combo(TM) stent vs. Biolimus eluting absorbable polymer coated BioMatrix Alpha(TM) stent in patients undergoing percutaneous coronary intervention. Rationale and s
    Am Heart J. 2025 Jan 25:S0002-8703(25)00013-4. doi: 10.1016/j.ahj.2025.
    PubMed     Abstract available


  5. VELDTMAN GR, Abualsaud A, Cohen S, Ordonez MV, et al
    Fontan circulation and systemic disease - a retrospective cohort analysis over 35 years of follow-up.
    Am Heart J. 2025;279:40-49.
    PubMed     Abstract available


    December 2024
  6. CASSESE S, Simonetti F, Covarrubias HAA, Janisch M, et al
    Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy: Design and Rationale of ISAR-WAVE Trial.
    Am Heart J. 2024 Dec 20:S0002-8703(24)00337-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  7. AARTS HM, Hemelrijk KI, Broeze GM, van Ginkel DJ, et al
    Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: rationale and design of the PRO-TAVI trial: the PRO-TAVI trial: rationale and design.
    Am Heart J. 2024 Dec 12:S0002-8703(24)00332-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    November 2024
  8. REDDY KP, Shultz K, Eberly LA, Khatana SAM, et al
    Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population.
    Am Heart J. 2024 Nov 27:S0002-8703(24)00302-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  9. ABRAHAM B, Suppah M, Farina J, Botros M, et al
    Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement.
    Am Heart J. 2024 Nov 12:S0002-8703(24)00295-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  10. IANNOPOLLO G, Cocco M, Leone A, Sacca S, et al
    TRanscatheter Aortic-Valve Implantation with or without on-site Cardiac Surgery: the TRACS trial: TAVI in centers without on-site cardiac surgery.
    Am Heart J. 2024 Nov 4:S0002-8703(24)00281-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    October 2024
  11. BARONE-ROCHETTE G, Vanzetto G, Danchin N, Steg PG, et al
    Rationale and design of the multicentric randomized EVAOLD trial: evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia.
    Am Heart J. 2024 Oct 22:S0002-8703(24)00274-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  12. THURAIAIYAH J, Jorgensen TH, Jensen JM, Fuchs A, et al
    Prospective study on the impact of different anti-thrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves - The NOTION-4 trial: Anti-thrombotic therapy and TAV-HALT.
    Am Heart J. 2024 Oct 5:S0002-8703(24)00264-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    September 2024
  13. DE COCK E, Kautbally S, Timmermans F, Bogaerts K, et al
    Low-dose colchicine for the prevention of cardiovascular events after percutaneous coronary intervention: rationale and design of the COL BE PCI trial: Short title: Rationale and design of the COL BE PCI trial.
    Am Heart J. 2024 Sep 2:S0002-8703(24)00225-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  14. GATTI G, Fiore A, Ismail M, Dralov A, et al
    Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study.
    Am Heart J. 2024;275:108-118.
    PubMed     Abstract available


    August 2024
  15. DISMORR M, Granbom-Koski M, Ellfors E, Ruck A, et al
    Sex differences and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Aug 9:S0002-8703(24)00185-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  16. STAHLI BE, Linke A, Westermann D, Van Mieghem NM, et al
    A Randomized Comparison of the Treatment Sequence of Percutaneous Coronary Intervention and Transcatheter Aortic Valve Implantation: Rationale and Design of the TAVI PCI Trial.
    Am Heart J. 2024 Aug 7:S0002-8703(24)00184-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  17. MEDINA CK, Barnes SG, Felker GM, Mentz RJ, et al
    Severe obesity among patients with left ventricular assist devices.
    Am Heart J. 2024;274:130-133.
    PubMed     Abstract available


  18. TERKELSEN CJ, Thim T, Freeman P, Dahl JS, et al
    Randomized comparison of TAVI valves: The Compare-TAVI trial.
    Am Heart J. 2024;274:84-94.
    PubMed     Abstract available


  19. DUARTE VE, Yamamura K, Economy KE, Graf JA, et al
    The effects of pregnancy in subjects with repaired tetralogy of Fallot.
    Am Heart J. 2024;274:95-101.
    PubMed     Abstract available


    July 2024
  20. BUTT JH, Yafasova A, Thein D, Begun X, et al
    Burden of Hospitalization During the First Year Following Transcatheter and Surgical Aortic Valve Replacement.
    Am Heart J. 2024 Jul 29:S0002-8703(24)00180-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  21. ERBAY A, Penzel L, Abdelwahed YS, Heuberger A, et al
    Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease.
    Am Heart J. 2024 Jul 19:S0002-8703(24)00177-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  22. ELLFORS E, Dismorr M, Ruck A, Settergren M, et al
    Predicted prosthesis-patient mismatch and long-term clinical outcomes after transcatheter aortic valve replacement: a SWEDEHEART study.
    Am Heart J. 2024 Jul 18:S0002-8703(24)00175-3. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  23. PERSITS I, Mirzai S, Sarnaik KS, Volk MC, et al
    Sarcopenia and Frailty in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Am Heart J. 2024 Jul 18:S0002-8703(24)00173-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  24. POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al
    Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum Cardiomyopathy.
    Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  25. YANG Y, Chu TC, Suthar D, Beshish AG, et al
    Association of patient-level characteristics with long-term outcomes after Fontan palliation: Rationale, design, and baseline characteristics of the Pediatric Cardiac Care Consortium Fontan cohort study.
    Am Heart J. 2024;273:111-120.
    PubMed     Abstract available


    June 2024
  26. ABOU-KARAM R, Tanguturi V, Cheng F, Elmariah S, et al
    Trial Designs A44002PZS Electronic Physician Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: Rationale, design, and methods of the randomized controlled DETECT AS Trial.
    Am Heart J. 2024 Jun 29:S0002-8703(24)00163-7. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  27. WU ZM, Kan J, Ye F, You W, et al
    PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study.
    Am Heart J. 2024 Jun 26:S0002-8703(24)00157-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  28. MIYAWAKI N, Ishizu K, Shirai S, Miyahara K, et al
    Impact of the Clinical Frailty Scale on Long-term Outcomes After Transcatheter Aortic Valve Implantation.
    Am Heart J. 2024 Jun 12:S0002-8703(24)00139-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  29. BRUNO F, Rampone JM, Islas F, Gorla R, et al
    Echocardiographic and clinical features of patients developing prosthesis-patient mismatch after TAVR: insights from the Recovery TAVR registry.
    Am Heart J. 2024 Jun 3:S0002-8703(24)00137-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    May 2024
  30. RICHARDSON C, Gilbert T, Aslam S, Brookes CL, et al
    Rationale and design of the Early valve replacement in severe ASYmptomatic Aortic Stenosis Trial.
    Am Heart J. 2024 May 29:S0002-8703(24)00128-5. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  31. LUPU L, Haberman D, Chitturi KR, Wermers JP, et al
    Overview of 2024 FDA Advisory Panel Meeting on the TriClip Transcatheter Tricuspid Valve Repair System.
    Am Heart J. 2024 May 29:S0002-8703(24)00126-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  32. KIM Y, Park H, Yoon HJ, Suh J, et al
    Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guidance for Coronary Stent Implantation (FLASH): Study Protocol for a Randomized Controlled Non-Inferiority Trial.
    Am Heart J. 2024 May 7:S0002-8703(24)00119-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  33. ZHANG F, Tian M, Wang X, Zhang H, et al
    Rationale and design of a Single-center Randomized Trial to Compare the Graft Patency between the Radial Artery and the No-touch Saphenous Vein in Coronary Artery Bypass Grafting Surgery (GRAFT-CAB Study).
    Am Heart J. 2024 May 4:S0002-8703(24)00117-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  34. LEMLEY BA, Okunowo O, Ampah SB, Wu L, et al
    Effect of patient factors, center, and era on Fontan timing: An observational study using the Pediatric Health Information Systems Database.
    Am Heart J. 2024;271:156-163.
    PubMed     Abstract available


  35. GUO Y, Liu X, Li R, Ng S, et al
    Comparison of Down Sizing Strategy (HANGZHOU Solution) and Standard Annulus Sizing Strategy in type 0 bicuspid aortic stenosis patients undergoing transcatheter aortic valve replacement: Rationale and design of a randomized clinical trial.
    Am Heart J. 2024 May 1:S0002-8703(24)00098-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    April 2024
  36. KIM MC, Ahn JH, Hyun DY, Lim Y, et al
    Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
    Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  37. ETIWY M, Flannery LD, Li SX, Morrison FJ, et al
    Examining Lack of Referrals to Heart Valve Specialists as Mechanisms of Potential Underutilization of Aortic Valve Replacement.
    Am Heart J. 2024 Apr 13:S0002-8703(24)00093-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    March 2024
  38. GUINOT PG, Desebbe O, Besch G, Guerci P, et al
    Prospective randomized double-blind study to evaluate the superiority of Vasopressin versus Norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial).
    Am Heart J. 2024 Mar 14:S0002-8703(24)00068-1. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  39. KRUCOFF M, Spirito A, Baber U, Sartori S, et al
    Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
    Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  40. DOU D, Yuan S, Jia Y, Wang Y, et al
    The protocol of enhanced recovery after cardiac surgery in adult patients: a stepped wedge cluster randomized trial.
    Am Heart J. 2024 Mar 2:S0002-8703(24)00051-6. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  41. KIM M, Ahn JM, Kang DY, Kim MJ, et al
    Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial.
    Am Heart J. 2024;269:167-178.
    PubMed     Abstract available


    February 2024
  42. ZHANG J, Kong XQ, Gao XF, Chen J, et al
    Transfemoral transcatheter aortic valve replacement with VitaFlow(TM) valve for pure native aortic regurgitation in patients with high surgical risk: Rationale and design of a prospective, multicenter, and randomized SEASON-AR trial.
    Am Heart J. 2024 Feb 25:S0002-8703(24)00049-8. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  43. KEDHI E, Rroku A, Hermanides RS, Dambrink JH, et al
    TransCatheter Aortic Valve Implantation and Fractional Flow Reserve-Guided Percutaneous Coronary Intervention versus Conventional Surgical Aortic Valve Replacement and Coronary Bypass Grafting for Treatment of Patients with Aortic Valve Stenosis and M
    Am Heart J. 2024 Feb 1:S0002-8703(24)00019-X. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    January 2024
  44. ASHWAT E, Brown JA, Yousef S, Ahmad D, et al
    Radial Artery versus Right Internal Mammary Artery as a Second Conduit during Coronary Artery Bypass Grafting.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00015-2. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


  45. JAMMOUL N, Dupasquier V, Akodad M, Meunier PA, et al
    Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial.
    Am Heart J. 2024 Jan 20:S0002-8703(24)00014-0. doi: 10.1016/j.ahj.2024.
    PubMed     Abstract available


    December 2023
  46. HEGEMAN RRMJJ, van Ginkel DJ, Langle S, Timmers L, et al
    Preoperative CT-imaging with patient-specific computer simulation in transcatheter aortic valve implantation: Design and rationale of the GUIDE-TAVI trial.
    Am Heart J. 2023 Dec 30:S0002-8703(23)00360-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  47. GENEREUX P, Schwartz A, Oldemeyer B, Cohen DJ, et al
    Design and Rationale of the Evaluation of Transcatheter Aortic Valve Replacement Compared to SurveilLance for Patients with AsYmptomatic Severe Aortic Stenosis: The EARLY TAVR Trial.
    Am Heart J. 2023 Dec 4:S0002-8703(23)00326-5. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  48. DILLEN DMM, Vlaar PJ, Vermeer AJE, Paradies V, et al
    Bifurcation PCI with a hybrid strategy with drug- eluting balloons versus a stepwise provisional two- stent strategy: Rationale and design of the hybrid DEB study.
    Am Heart J. 2023;266:168-175.
    PubMed     Abstract available


    November 2023
  49. STRANGE JE, Nouhravesh N, Schou M, Christensen DM, et al
    High-risk admission prior to transcatheter aortic valve replacement and subsequent outcomes: Preceding events and outcomes after TAVR.
    Am Heart J. 2023 Nov 14:S0002-8703(23)00311-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  50. FOOTE HP, Thibault D, Gonzalez CD, Hill GD, et al
    Center-level factors associated with shorter length of stay following stage 1 palliation: An analysis of the national pediatric cardiology quality improvement collaborative registry.
    Am Heart J. 2023;265:143-152.
    PubMed     Abstract available


    October 2023
  51. BARON SJ, Ryan MP, Chikermane SG, Thompson C, et al
    Long-Term Risk of Reintervention after Transcatheter Aortic Valve Replacement.
    Am Heart J. 2023 Oct 21:S0002-8703(23)00296-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  52. BAINEY KR, Wood DA, Bossard M, Campo G, et al
    Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease (COMPLETE-AGE).
    Am Heart J. 2023 Oct 21:S0002-8703(23)00297-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    September 2023
  53. CHEEMA HA, Khan AA, Ahmad AH, Khan AA, et al
    Prophylactic corticosteroids for cardiac surgery in children: A systematic review and meta-analysis.
    Am Heart J. 2023 Sep 14:S0002-8703(23)00279-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  54. OHUCHI H, Mori A, Kurosaki K, Shiraishi I, et al
    Prevalence and clinical correlates and characteristics of "Super Fontan".
    Am Heart J. 2023;263:93-103.
    PubMed     Abstract available


  55. O'BYRNE ML, Song L, Huang J, Lemley B, et al
    Attributable mortality benefit of digoxin treatment in hypoplastic left heart syndrome after the Norwood operation: An instrumental variable-based analysis using data from the Pediatric Health Information Systems Database.
    Am Heart J. 2023;263:35-45.
    PubMed     Abstract available


    July 2023
  56. PARK S, Rha SW, Choi BG, Kim W, et al
    Efficacy and Safety of Cilostazol-Based Triple Antiplatelet Therapy Compared with Clopidogrel-Based Dual Antiplatelet Therapy in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Multicenter, Rando
    Am Heart J. 2023 Jul 3:S0002-8703(23)00172-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    June 2023
  57. SEGUCHI M, Aytekin A, Steiger L, Nicol P, et al
    Near-infrared Spectroscopy-Intravascular Ultrasound to Improve Assessment of Coronary Artery Disease Severity in Patients Referred for Transcatheter Aortic Valve Implantation (The IMPACTavi registry): Design and Rationale.
    Am Heart J. 2023 Jun 12:S0002-8703(23)00159-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  58. MADSEN CL, Park-Hansen J, Irmukhamedov A, Carranza CL, et al
    The Left Atrial Appendage Closure by Surgery-2 (LAACS-2) trial protocol Rationale and design of a randomized multicenter trial investigating if left atrial appendage closure prevents stroke in patients undergoing open-heart surgery irrespective of pre
    Am Heart J. 2023 Jun 9:S0002-8703(23)00147-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  59. BUJAK K, Vidal-Cales P, Gabani R, Rinaldi R, et al
    Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study.
    Am Heart J. 2023 Jun 4:S0002-8703(23)00141-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  60. SHECHTER A, Koren O, Skaf S, Makar M, et al
    Transcatheter Edge-to-Edge Repair for Chronic Functional Mitral Regurgitation in Patients with Very Severe Left Ventricular Dysfunction.
    Am Heart J. 2023 Jun 3:S0002-8703(23)00138-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  61. STAHL A, Havers-Borgersen E, Ostergaard L, Petersen JK, et al
    Hemodialysis and its impact on Patient Characteristics, Microbiology, Cardiac Surgery, and Mortality in Infective Endocarditis.
    Am Heart J. 2023 Jun 2:S0002-8703(23)00135-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    May 2023
  62. BEGUN X, Butt JH, Kristensen SL, Weeke PE, et al
    Patient Characteristics and Long-term Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation in a Failed Surgical Prosthesis versus in a Native Valve: A Danish nationwide study.
    Am Heart J. 2023 May 11:S0002-8703(23)00118-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  63. SELAMET TIERNEY ES, Palaniappan L, Leonard M, Long J, et al
    Design and rationale of re-energize fontan: Randomized exercise intervention designed to maximize fitness in fontan patients.
    Am Heart J. 2023;259:68-78.
    PubMed     Abstract available


    April 2023
  64. LAURIDSEN MD, Valentin JB, Strange JE, Jacobsen PA, et al
    Mortality in patients with chronic obstructive pulmonary disorder undergoing transcatheter aortic valve replacement: The importance of chronic obstructive pulmonary disease exacerbation.
    Am Heart J. 2023;262:100-109.
    PubMed     Abstract available


  65. COISNE A, Aghezzaf S, Butruille L, Woitrain E, et al
    Incidence, Source, and Prognostic Impact of Major Bleeding Across the Spectrum of Aortic Stenosis.
    Am Heart J. 2023 Apr 24:S0002-8703(23)00099-6. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  66. RIKKEN SA, Bor WL, Selvarajah A, Zheng KL, et al
    Pre-Percutaneous Coronary Intervention Zalunfiban Dose-Response Relationship to Target Vessel Blood Flow at Initial Angiogram in ST-Elevation Myocardial Infarction - A Post Hoc Analysis of the Cel-02 Phase IIa Study.
    Am Heart J. 2023 Apr 21:S0002-8703(23)00096-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  67. GRIFFITHS RI, Cavalcante R, McGovern AM, Bhave A, et al
    Cost to Medicare of Acute Kidney Injury in Percutaneous Coronary Intervention.
    Am Heart J. 2023 Apr 2:S0002-8703(23)00075-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  68. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    PubMed     Abstract available


  69. DEMIREL C, Tomii D, Heg D, Okuno T, et al
    Incidental detection of malignancy during pre-procedural workup for transcatheter aortic valve implantation: a longitudinal cohort study.
    Am Heart J. 2023 Apr 1:S0002-8703(23)00072-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    March 2023
  70. DESCAMPS R, Amour J, Besnier E, Bougle A, et al
    Perioperative individualized hemodynamic optimization according to baseline mean arterial pressure in cardiac surgery patients: Rationale and design of the OPTIPAM randomized trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00067-4. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  71. RONG LQ, Franco AD, Rahouma M, Dimagli A, et al
    Postoperative pericardial effusion, pericardiotomy and atrial fibrillation: an explanatory analysis of the PALACS trial.
    Am Heart J. 2023 Mar 17:S0002-8703(23)00063-7. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  72. GAUTIER A, Roffi M, Laanmets P, Munir S, et al
    Complementary evidence on the performance of coronary stents generated by a randomized controlled trial and a worldwide registry.
    Am Heart J. 2023 Mar 15:S0002-8703(23)00061-3. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    February 2023
  73. ALMOND CS, Sleeper LA, Rossano JW, Bock MJ, et al
    The TEAMMATE Trial: Study Design and Rationale Tacrolimus and Everolimus Against TACROLIMUS and MMF in Pediatric Heart Transplantation Using the Major Adverse Transplant Event (MATE) Score.
    Am Heart J. 2023 Feb 22:S0002-8703(23)00038-8. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  74. PARK S, Rha SW, Choi BG, Cho JH, et al
    Immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: results from a prematurely discontinued randomized multicenter trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00026-1. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  75. CONEN D, Popova E, Wang MK, Chan MTV, et al
    Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial.
    Am Heart J. 2023 Feb 6:S0002-8703(23)00025-X. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    January 2023
  76. MALM CJ, Alfredsson J, Erlinge D, Gudbjartsson T, et al
    Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial): Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial.
    Am Heart J. 2023 Jan 18:S0002-8703(23)00018-2. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  77. SAITO Y, Inohara T, Kohsaka S, Wada H, et al
    Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide J-PCI registry.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00017-0. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


  78. HAVERS-BORGERSEN E, Butt JH, Strange J, Carranza CL, et al
    Mortality and Rehospitalization after Mitral Valve Surgery as a Function of Age and Key Comorbidities.
    Am Heart J. 2023 Jan 12:S0002-8703(23)00016-9. doi: 10.1016/j.ahj.2023.
    PubMed     Abstract available


    December 2022
  79. CUBEDDU RJ, Murphy SME, Asher CR, Garcia SA, et al
    Association of ACEI/ARB and Statin Prescribing Patterns with Mortality After Transcatheter Aortic Valve Replacement (TAVR): Findings from Real-World Claims Data.
    Am Heart J. 2022 Dec 31:S0002-8703(22)00333-7. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available


  80. RIKKEN SAOF, Selvarajah A, Hermanides RS, Coller BS, et al
    Pre-hospital treatment with zalunfiban (RUC-4) in patients with ST- Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Rationale and design of the CELEBRATE trial.
    Am Heart J. 2022 Dec 30:S0002-8703(22)00336-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available


  81. SKIBNIEWSKI M, Venetsanos D, Ahlsson A, Batra G, et al
    Long-term antithrombotic therapy after coronary artery bypass grafting in patients with preoperative atrial fibrillation. A nationwide observational study from the SWEDEHEART registry.
    Am Heart J. 2022 Dec 5:S0002-8703(22)00321-0. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available


  82. GOLDBERG CS, Gaynor JW, Mahle WT, Ravishankar C, et al
    The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptations.
    Am Heart J. 2022;254:216-227.
    PubMed     Abstract available


  83. TEHRANI DM, Kim JS, Hsu JJ, Nsair A, et al
    Early trends in cardiac allograft vasculopathy after implementation of the 2018 donor heart allocation policy in the United States.
    Am Heart J. 2022;254:23-29.
    PubMed     Abstract available


  84. MORI M, Mark DB, Khera R, Lin H, et al
    Identifying quality of life outcome patterns to inform treatment choices in ischemic cardiomyopathy.
    Am Heart J. 2022;254:12-22.
    PubMed     Abstract available


    November 2022
  85. DE WINTER RW, Walsh SJ, Hanratty CG, Spratt JC, et al
    Percutaneous Coronary Intervention of Native Coronary Artery versus Saphenous Vein Graft in Patients with Prior Coronary Artery Bypass Graft Surgery: Rationale and Design of the Multicenter, Randomized PROCTOR Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00296-4. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available


  86. NUIS RJ, van Belle E, Teles R, Blackman D, et al
    BA lloon Expandable vs. SElf Expanding Transcatheter VaLve for Degenerated BioprosthesIs: Design and Rationale of the BASELINE Trial.
    Am Heart J. 2022 Nov 18:S0002-8703(22)00295-2. doi: 10.1016/j.ahj.2022.
    PubMed     Abstract available


  87. SAVITZ ST, Leong T, Sung SH, Kitzman DW, et al
    Predicting Short-term Outcomes After Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Am Heart J. 2022 Nov 10. pii: S0002-8703(22)00286.
    PubMed     Abstract available


    October 2022
  88. CHUNG M, Butala NM, Faridi KF, Almarzooq ZI, et al
    Days at Home after Transcatheter or Surgical Aortic Valve Replacement in High-Risk Patients.
    Am Heart J. 2022 Oct 26. pii: S0002-8703(22)00275.
    PubMed     Abstract available


  89. NELSON AJ, Inohara T, Rao SV, Kaltenbach LA, et al
    Comparing the classification of Percutaneous Coronary Interventions using the 2012 and 2017 Appropriate Use Criteria: Insights from 245,196 patients in the NCDR CathPCI registry.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00199.
    PubMed     Abstract available


  90. OLIVA A, Castiello DS, Franzone A, Condorelli G, et al
    P2Y12 Inhibitors Monotherapy in Patients Undergoing Complex Vs. Non-Complex Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00201.
    PubMed     Abstract available


  91. SABBAH M, Veien K, Niemela M, Freeman P, et al
    Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third Nordic Aortic Valve Intervention Trial - NOTION-3.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00204.
    PubMed     Abstract available


  92. SPEHAR SM, Seth M, Henke P, Alaswad K, et al
    Race and Outcomes after Percutaneous Coronary Intervention: Insights from the Michigan Blue Cross Blue Shield Cardiovascular Consortium.
    Am Heart J. 2022 Oct 7. pii: S0002-8703(22)00196.
    PubMed     Abstract available


    September 2022
  93. MYLONAS KS, Tasoudis PT, Pavlopoulos D, Kanakis M, et al
    Aortic valve neocuspidization using the Ozaki technique: A meta-analysis of reconstructed patient-level data.
    Am Heart J. 2022 Sep 14. pii: S0002-8703(22)00186.
    PubMed     Abstract available


  94. HERSCOVICI DM, Boggs KM, Cash RE, Espinola JA, et al
    Development of a Unified National Database of Primary Percutaneous Coronary Intervention Centers with Co-located Emergency Departments, 2020.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00188.
    PubMed     Abstract available


    August 2022
  95. PARLOW S, Di Santo P, Jung RG, Fam N, et al
    Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock - Design and Rationale of the CAPITAL MINOS Trial.
    Am Heart J. 2022 Aug 21. pii: S0002-8703(22)00169.
    PubMed     Abstract available


  96. KIKANO S, Breeyear J, Aka I, Edwards TL, et al
    Association Between Nitric Oxide Synthase 3 Genetic Variant and Acute Kidney Injury Following Pediatric Cardiac Surgery.
    Am Heart J. 2022 Aug 18. pii: S0002-8703(22)00164.
    PubMed     Abstract available


  97. SALZMANN S, Laferton JAC, Shedden-Mora MC, Horn N, et al
    Pre-surgery optimization of patients' expectations to improve outcome in heart surgery: Study protocol of the randomized controlled multi-center PSY-HEART-II trial.
    Am Heart J. 2022 Aug 5. pii: S0002-8703(22)00161.
    PubMed     Abstract available


    June 2022
  98. HOLLANDER SA, Barkoff L, Giacone H, Adamson GT, et al
    Risk Factors and Outcomes of Sudden Cardiac Arrest in Pediatric Heart Transplant Recipients.
    Am Heart J. 2022 Jun 12. pii: S0002-8703(22)00127.
    PubMed     Abstract available


  99. TOMII D, Pilgrim T, Heg D, Reineke D, et al
    Reply: Correlation of aortic root dimensions in patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2022;248:166-168.
    PubMed    


  100. GUPTA K, Lee JC
    Assessment of sinus of valsalva dimensions before TAVI: An independent predictor of worse outcomes?
    Am Heart J. 2022;248:165.
    PubMed    


    May 2022
  101. PARK DY, Wang P, An S, Grimshaw AA, et al
    Shortening the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Systematic Review and Meta-analysis: Shortening DAPT after PCI for ACS.
    Am Heart J. 2022 May 30. pii: S0002-8703(22)00113.
    PubMed     Abstract available


  102. PAHUJA M, Case BC, Molina EJ, Waksman R, et al
    Overview of the FDA's Circulatory System Devices Panel virtual meeting on the TransMedics Organ Care System (OCS) Heart - portable extracorporeal heart perfusion and monitoring system.
    Am Heart J. 2022;247:90-99.
    PubMed     Abstract available


    April 2022
  103. GARG A, Rout A, Farhan S, Waxman S, et al
    Dual Antiplatelet Therapy Duration after Percutaneous Coronary Intervention using Drug Eluting Stents in High Bleeding Risk Patients: A Systematic Review and Meta-analysis.
    Am Heart J. 2022 Apr 15. pii: S0002-8703(22)00076.
    PubMed     Abstract available


  104. BAGIELLA E, Puskas JD, Moskowitz AJ, Gelijns AC, et al
    Rationale and design of a randomized trial evaluating an external support device for saphenous vein coronary grafts.
    Am Heart J. 2022;246:12-20.
    PubMed     Abstract available


    March 2022
  105. VERMA S, Rathwell S, Fremes S, Zheng Y, et al
    Associated Factors and Clinical Outcomes in Mechanical Circulatory Support use in Patients Undergoing High Risk On-Pump Cardiac Surgery: Insights from the LEVO-CTS trial.
    Am Heart J. 2022 Mar 6. pii: S0002-8703(22)00046.
    PubMed     Abstract available


    February 2022
  106. O'NEILL WW, Anderson M, Burkhoff D, Grines CL, et al
    Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF.
    Am Heart J. 2022 Feb 19. pii: S0002-8703(22)00039.
    PubMed     Abstract available


  107. LINDER M, Higgen FL, Voigtlander L, Weimann J, et al
    Stroke events after transcatheter aortic valve implantation: Temporal relationships and affected brain regions.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00030.
    PubMed     Abstract available


    January 2022
  108. OTOWA K, Kohsaka S, Sawano M, Matsuura S, et al
    One-year Outcome after Percutaneous Coronary Intervention in Nonagenarians: Insights from the J-PCI OUTCOME Registry.
    Am Heart J. 2022 Jan 8. pii: S0002-8703(22)00004.
    PubMed     Abstract available


  109. TERTULIEN T, Roberts MB, Eaton CB, Cene CW, et al
    Association Between Race/Ethnicity and Income on the Likelihood of Coronary Revascularization Among Postmenopausal Women with Acute Myocardial Infarction: Women's Health Initiative Study.
    Am Heart J. 2022 Jan 6. pii: S0002-8703(21)00496.
    PubMed     Abstract available


  110. HERRMANN HC, Abdel-Wahab M, Attizzani GF, Batchelor W, et al
    Rationale and design of the SMall Annuli Randomized To Evolut or SAPIEN Trial (SMART Trial).
    Am Heart J. 2022;243:92-102.
    PubMed     Abstract available


  111. BUTALA NM, Song Y, Shen C, Cohen DJ, et al
    Effect of intensive versus limited monitoring on clinical trial conduct and outcomes: A randomized trial.
    Am Heart J. 2022;243:77-86.
    PubMed     Abstract available


    December 2021
  112. CHRISTENSEN DM, Schjerning AM, Sindet-Pedersen C, Lamberts M, et al
    Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a nationwide registry-based study.
    Am Heart J. 2021 Dec 10. pii: S0002-8703(21)00471.
    PubMed     Abstract available


    November 2021
  113. I D, Okuno T, Heg D, Grani C, et al
    Sinus of Valsalva Dimension and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation: SOV dilatation in TAVI patients.
    Am Heart J. 2021 Nov 14. pii: S0002-8703(21)00447.
    PubMed     Abstract available


  114. HUANG D, Wu H, Zhou J, Zhong X, et al
    Intravenous Nicorandil During Primary Percutaneous Coronary intervention in Patients with ST-Elevation Myocardial Infarction: Rationale and Design of the CLinical Efficacy and sAfety of intravenous Nicorandil (CLEAN) trial.
    Am Heart J. 2021 Nov 13. pii: S0002-8703(21)00448.
    PubMed     Abstract available


  115. KOSHY AN, Dinh DT, Fulcher J, Brennan AL, et al
    Long-Term Mortality in Asymptomatic Patients with Stable Ischemic Heart Disease undergoing Percutaneous Coronary Intervention.
    Am Heart J. 2021 Nov 12. pii: S0002-8703(21)00449.
    PubMed     Abstract available


  116. YEH RW, Bachinsky W, Stoler R, Bateman C, et al
    Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis.
    Am Heart J. 2021;241:101-107.
    PubMed     Abstract available


    October 2021
  117. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    PubMed     Abstract available


    September 2021
  118. STRANGE JE, Sindet-Pedersen C, Gislason GH, Torp-Pedersen C, et al
    Title: Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study.
    Am Heart J. 2021 Sep 26. pii: S0002-8703(21)00239.
    PubMed     Abstract available


  119. CLARK KA, Chouairi F, Kay B, Reinhardt SW, et al
    Trends in Transcatheter and Surgical Aortic Valve Replacement in the United States, 2008-2018.
    Am Heart J. 2021 Sep 24. pii: S0002-8703(21)00232.
    PubMed     Abstract available


    June 2021
  120. YONG CM, Spinelli KJ, Chiu ST, Jones B, et al
    Cardiovascular Procedural Deferral and Outcomes over COVID-19 Pandemic Phases: A Multi-Center Study.
    Am Heart J. 2021 Jun 25. pii: S0002-8703(21)00167.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Thoracic Surgery is free of charge.